7.91Open7.91Pre Close0 Volume10 Open Interest1.00Strike Price0.00Turnover871.32%IV5.32%PremiumDec 20, 2024Expiry Date7.46Intrinsic Value100Multiplier6DDays to Expiry0.45Extrinsic Value100Contract SizeAmericanOptions Type0.9921Delta0.0022Gamma1.13Leverage Ratio-0.0150Theta0.0002Rho1.12Eff Leverage0.0002Vega
Anavex Life Sciences Stock Discussion
$Sunshine Biopharma (SBFM.US)$
$Rumble (RUM.US)$
Got a few superbouncy balls this evening.
making me dizzy 🤣
Anavex Life Sciences to Report New Long-Term Oral Blarcamesine Phase IIb/III Alzheimer’s Disease Data at J.P. Morgan 2025 Healthcare Conference
Anavex Life Sciences (Nasdaq: AVXL) announced it will present new long-term data from the Phase IIb/III ATTENTION-AD Open-Label-Extension (OLE) trial for blarcamesine in early Alzheimer's disease at the J.P. Morgan 2025 Healthcare Conference. The presentation will showcase data from up to 144 weeks of continuous treatm...
hmmmmm 🤔 looks very similar throughout the market starting at 3 pm
No comment yet